The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,

Slides:



Advertisements
Similar presentations
Responding to the Opioid Addiction Epidemic
Advertisements

The purpose of this overview is to update the facts pertaining to the possibility of upward trends related to heroin trafficking and/or abuse in the Commonwealth.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Opioids for Chronic Pain: Course Overview William Morrone, D.O., M.S. Medical Director, Hospice of Michigan Assistant Director, Family Medicine Synergy.
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon.
National Institute on Drug Abuse P rescription D rug A buse: An Escalating Public Health Threat P rescription D rug A buse: An Escalating Public Health.
OVERDOSE SOLUTIONS 2013 OVERDOSE DATA FOR ALLEGHENY COUNTY Jennifer Janssen Manager Toxicology Laboratory Allegheny County Office of the Medical Examiner.
William A. Lanier, DVM, MPH Kristina Russell, MPH Utah Department of Health Risk Factors for Prescription Opioid Death – Utah, 2008–2009 Office of Surveillance,
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Recovery Housing and The National Drug Control Strategy David K. Mineta Deputy Director, Demand Reduction Office of National Drug Control Policy (ONDCP)
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Serving our community by improving health The Addiction Crisis November 2014.
Addressing the Substance Abuse Epidemic in Tennessee
A Day Without Pain ? Mel Pohl, MD, FASAM Medical Director Las Vegas Recovery Center.
Chronic Pain and Addiction: A Challenging and CoOccurring Disorder Mel Pohl, MD, FASAM Medical Director Las Vegas Recovery Center.
Drug Diversion, Sources, and Extent: United States Case Study Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist Pain & Policy Studies.
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Brian Emerson Medical Consultant, Population and Public Health Division BC Ministry of Health
Saves Lives Oklahoma’s Plan to Reduce Prescription Drug Abuse and Prevent Overdose.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
H.R Prescription drug abuse prevention and treatment Act of 2011.
Ph: Disclaimer: Information on this page is not a substitute for medical consultation.
Ohio’s Opiate Epidemic
State of the State in outcomes: Prescription drug overdoses Karin A. Mack, PhD Senior Behavioral Scientist Prescription Drug Overdose Team National Center.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
SARAH M. BAGLEY, MD ASSISTANT PROFESSOR OF MEDICINE AND PEDIATRICS BOSTON UNIVERSITY SCHOOL OF MEDICINE AMERSA ANNUAL CONFERENCE NOVEMBER 5, 2015 Overdose.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Increase in Methadone Related Deaths Lon R. Hays, M.D., M.B.A. Greg Davis, M.D.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
More About Pain and Addiction Mel Pohl, MD, DFASAM Medical Director Las Vegas Recovery Center.
Considerations for NJ Behavioral Health Planning Council and Citizens Advisory Council Tom Pyle MBA, MS, CPRP Psychodyssey Services
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible.
State Targeted Response to Opioid Crisis
OPIOID EPIDEMIC.
Illinois’ 1115 Behavioral Health Transformation Waiver
Center for Social Work Research The University of Texas at Austin
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Cover slide.
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
5th Annual Empowering Local Leadership Conference
Opioid Addiction in Tennessee
Joann Yoon Kang, JD Policy and Partnerships Team Lead
Partnership with Providers: Addressing the Opioid Crisis
THE OPIOID CRISIS Mississippi Board of Nursing
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
The Impact of Market Based Healthcare on the Opioid Epidemic
Understanding the Opioid Epidemic
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Addiction and the Opioid Crisis: HHS Update
Richard C. Dart, MD, PhD Executive Director, RADARS System
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
The Myths and Realities of the Opioid Epidemic AMERSA November 3, 2017
Chronic Pain Treatments:
Addiction Why It’s YOUR Business
Opioids in Butte County
Using Data for Change Barry T. Schmidt, MPH, CPC-R
New Jersey Addictions Charts and Graphs (v. 1.0, as of March 15, 2016)
Strategic Initiatives to Address Opioid Overdose & Addiction
Presentation transcript:

The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School for Social Policy and Management, Brandeis University Research Professor, Global Institute of Public Health, New York University

2 Opium

Heroin Cocaine 43,982 drug overdose deaths in 2013 Unintentional Drug Overdose Deaths United States, 1970–2007 National Vital Statistics System, Year

Drug Overdose Deaths by Major Drug Type, United States, 1999–2010 CDC, National Center for Health Statistics, National Vital Statistics System, CDC Wonder. Updated with 2010 mortality data.

Opioid Related Overdose Deaths United States,

6 Heroin admissions, by age group & race/ethnicity:

7 Death rates from overdoses of heroin or prescription opioid pain relievers (OPRs), by age group SOURCE: CDC. Increases in Heroin Overdose Deaths — 28 States, 2010 to 2012 MMWR. 2014, 63:

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 8

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 9

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 10

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 11

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 12

Primary non-heroin opiates/synthetics admission rates, by State (per 100,000 population aged 12 and over) 13

14

Unintentional overdose deaths involving opioid analgesics parallel per capita sales of opioid analgesics in morphine equivalents by year, U.S., Source: National Vital Statistics System, multiple cause of death dataset, and DEA ARCOS * 2007 opioid sales figure is preliminary. Number of Deaths Opioid sales (mg/person) *

Rates of Opioid Sales, OD Deaths, and Treatment, 1999–2010 CDC. MMWR 2011

17

18

Source: United States General Accounting Office: Dec. 2003, “OxyContin Abuse and Diversion and Efforts to Address the Problem.” Dollars Spent Marketing OxyContin ( )

Industry-funded “educational” messages Physicians are needlessly allowing patients to suffer because of “opiophobia.” Opioid addiction is rare in pain patients. Opioids can be easily discontinued. Opioids are safe and effective for chronic pain. 20

Industry-funded organizations campaigned for greater use of opioids Pain Patient Groups Professional Societies The Joint Commission The Federation of State Medical Boards 21

Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med Jan 10;302(2):123 Cited 824 times (Google Scholar) “The risk of addiction is much less than 1%” 22

N Engl J Med Jan 10;302(2):

Controlling the epidemic: A Three-pronged Approach Prevent new cases of opioid addiction. Treatment for people who are already addicted. Reduce supply from pill mills and the black- market. 25

26 Teenage brains may be more vulnerable to addiction

27 Nonmedical Use in College is Most Common in Students Prescribed Opioids as Children McCabe, S.E.; Teter, C.J.; and Boyd, C.J. “Illicit Use of Prescription Pain Medication Among College Students,” Drug and Alcohol Dependence77(1):37-47, 2005

28

How the opioid lobby frames the problem: Source: Slide presented by Lynn R. Webster MD at FDA meeting on hydrocodone upscheduling, January 25 th, 2013.

Pain Patients “Drug Abusers” 35% met DSM V criteria for an opioid use disorder 1 1. Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis. 2011;30: This is a false dichotomy Opioid harms are not limited to so-called “drug abusers” 92% of opioid OD decedents were prescribed opioids for chronic pain Johnson EM, Lanier WA, Merrill RM, et al. Unintentional Prescription Opioid-Related Overdose Deaths: Description of Decedents by Next of Kin or Best Contact, Utah, J Gen Intern Med Oct 16.

President Obama discussing the opioid addiction epidemic in West Virginia

Summary The U.S. is in the midst of a severe epidemic of opioid addiction To bring the epidemic to an end: – We must prevent new cases of opioid addiction –We must ensure access to treatment for people already addicted